Table 1.
Summary of PCV2/3 detection in 340 clinical samples using the established real-time PCR.
Samples | PCV2+ | PCV3+ | PCV2+ PCV3+ |
---|---|---|---|
Lung | 75/98 (76.5%) | 66/98 (67.3%) | 34/98 (34.7%) |
Lymph node | 93/162 (57.4%) | 75/162 (46.3%) | 51/162 (31.5%) |
Tonsil | 64/80 (80.0%) | 10/80 (12.5%) | 9/80 (11.3%) |
Total | 232/340 (68.2%) | 151/340 (44.4%) | 94/340 (27.6%) |